שווי כולל של החברה: Evolus, Inc. (EOLS)
Evolus, Inc. (EOLS) is expanding its aesthetic medicine business, focusing on European expansion and attracting younger clients through Jeuveau. However, intense competition and pressure from low-cost Asian alternatives are forcing the company to fight for clinic loyalty. Simultaneously, the company is implementing software for patient tracking and predictive analytics. This market valuation chart confirms these trends, with the current figure standing at 623.93.
Evolus, Inc. (EOLS) - פילוחי מדדים ודוחות פיננסיים
When screening assets, an investor uses this metric to determine the actual cost of acquiring a business by summing the market capitalization and net debt. The calculation logic of Enterprise Value (EV) allows for an assessment of the financial stability of Evolus, Inc. (EOLS) amid price wars with Asian competitors in the aesthetic medicine segment, revealing the real price of the asset inclusive of all credit obligations.